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Abstract
Purpose of Review Negative controls are a powerful tool to detect and adjust for
bias in epidemiological research. This paper introduces negative controls to a broader
audience and provides guidance on principled design and causal analysis based on a
formal negative control framework.
Recent Findings We review and summarize causal and statistical assumptions,
practical strategies, and validation criteria that can be combined with subject matter
knowledge to perform negative control analyses. We also review existing statistical
methodologies for detection, reduction, and correction of confounding bias, and briefly
discuss recent advances towards nonparametric identification of causal effects in a dou-
ble negative control design.
Summary There is great potential for valid and accurate causal inference lever-
aging contemporary healthcare data in which negative controls are routinely available.
Design and analysis of observational data leveraging negative controls is an area of
growing interest in health and social sciences. Despite these developments, further
effort is needed to disseminate these novel methods to ensure they are adopted by
practicing epidemiologists.
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confounding.
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1 Introduction
Despite ongoing efforts to improve study design and statistical analysis of epidemiological
research, failure to rule out non-causal explanation of empirical findings has prompted sub-
stantial discussions in the health science [1, 2]. A powerful tool increasingly recognized to
mitigate bias is negative control study design and analysis [3–5]. Negative controls have
a long history in laboratory experiments and epidemiology [3, 6–8]. However, they have
mainly been used to detect bias rather than to remove bias. More recent methodological
advances that enable both bias detection and bias removal have not been fully recognized.
As a result, the potential for valid and accurate causal inference leveraging contemporary
healthcare data with abundant negative controls has to date not been fully realized. This
paper aims to introduce negative controls to a broader audience and provide guidance on
principled design and causal analysis based on a formal negative control framework. We
focus on resolving bias due to unmeasured confounding in observational studies, although
negative controls have recently also been used to tackle a variety of biases such as selection
bias [3, 4, 9], measurement bias [3, 4], and homophily bias [10, 11] in both observational
studies and randomized trials [5].
1.1 Definition and notation
A negative control outcome (NCO) is a variable known not to be causally affected by the
treatment of interest. Likewise, a negative control exposure (NCE) is a variable known not to
causally affect the outcome of interest. To the extent possible, both NCO and NCE should be
selected such that they share a common confounding mechanism as the exposure and outcome
variables of primary interest, although this is not always necessary [12, 13]. These known-null
effects have been used to detect residual confounding bias: presence of an association between
the NCE and the outcome (or between the NCO and the exposure) constitutes compelling
evidence of residual confounding bias, while absence of such association implies no empirical
evidence of such bias. For example, in a study about the effects of influenza vaccination
on influenza hospitalization in the elderly (Figure 1), injury/trauma hospitalization was
considered as an NCO as it can not be causally affected by influenza vaccination, but may
be subject to the same confounding mechanism mainly driven by health-seeking behavior [14].
The authors found that despite efforts to control for confounding, influenza vaccination not
only appeared to reduce risk of influenza hospitalization after influenza season (risk ratio 0.82,
95% CI 0.73–0.92), but also appeared to reduce risk of injury/trauma hospitalization (risk
ratio 0.83, 95% CI 0.75–0.91). This was interpreted as evidence of bias due to inadequately
controlled confounding. Likewise, annual wellness visit history can be considered as an NCE
as it is unlikely to cause flu-related hospitalization.
In the following, we adopt the potential outcome framework which we use to formally
define causal effects as well as to articulate sufficient identification conditions to perform valid
causal inferences from observational data. We proceed under the fundamental assumption
that for each subject in the target population there exist a potential outcome variable Y (a),
that would be observed if possibly contrary to fact, the subject were exposed to treatment
value a, for all possible treatment values of a in a set A. In the common setting where the
treatment is dichotomous A = {0, 1}, the assumption states that each subject has a well
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Figure 1: An illustrating example of different types of negative controls: consider studying
the causal effect of flu shot (A) on influenza hospitalization (Y), subject to confounding
by unmeasured health-seeking behavior (U). Annual wellness visit history (Z) is an NCE
which does not causally affect Y. Injury/trauma hospitalization (W) is an NCO which is not
causally affected by A. Both Z and W are proxies of health-seeking behavior. Physician’s
prescribing preference (IV) is an instrumental variable which likely induces variation in the
choice of treatment, and may not affect the outcome other than through its influence on
the treatment. As discussed in Sections 1.1 and 3.1, both a valid instrumental variable and
an invalid instrumental variable associated with U are valid NCE. All arguments are made
implicitly conditional on measured covariates X. Independence between A and Z (or Y and
W) conditional on U is not necessary. See more examples in Table A.1 of the Appendix.
defined pair of potential outcomes (Y (0), Y (1)) corresponding to their outcome under active
treatment a = 1 and control treatment a = 0, respectively [15, 16]. In such setting, our goal
is to make inferences about the population average treatment effect (ATE) defined as ATE =
E[Y (1) − Y (0)]. Now, consider an observational study in which one observes independent
and identically distributed samples on (Y,A,X), where A is a subject’s observed binary
treatment assignment, Y is his/her observed outcome, and X are observed confounders of
the association between A and Y . We sometimes refer to A as primary treatment and Y
as primary outcome. We assume that the treatment is defined with enough specificity such
that among subjects with A = a, the observed outcome Y is a realization of the potential
outcome value Y (a), that is
Assumption 1 (Consistency). Y (a) = Y when A = a.
Much of the literature on causal inference in observational studies relies on the strong
assumption of no unmeasured confounding for the purpose of identification, i.e., A ⊥⊥ Y (a) |
X, which is sometimes referred to as ignorability assumption. This assumption essentially
rules out the existence of unmeasured common causes, denoted as U , of the treatment and
outcome variables – an untestable assumption which is often at the source of much skepticism
about causal interpretation of associations found in observational data. We do not make such
ignorability assumption to establish causation. Instead, we invoke the following assumption
that describes the relationship between treatment and outcome in the presence of both
measured and unmeasured confounding.
Assumption 2 (Latent ignorability). A ⊥⊥ Y (a) | U,X.
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In addition to (A, Y,X), suppose that one has also observed a secondary outcome W
and/or a secondary exposure Z, and let Y (a, z) and W (a, z) denote the corresponding coun-
terfactual values that would be observed had the primary treatment and secondary exposure
taken value (a, z). W and Z are formally defined as negative control outcome and exposure
variables provided that the following assumptions hold
Assumption 3 (Negative control outcome). W (a, z) = W and W ⊥⊥ A | U,X.
Assumption 4 (Negative control exposure). Y (a, z) = Y (a) and Z ⊥⊥ (Y (a),W ) | U,X.
Assumptions 3 and 4 entail: (1) there is no remaining unmeasured common cause between
(A,Z) and (Y,W ) conditional on (U,X); (2) there is no causal effect of Z on Y conditional
on U , A and X, and there is no causal effect of A and Z on W conditional on U and X,
which are referred to as the exclusion restrictions. We refer to a pair of W and Z as the
double negative control. It is not necessary to have both NCO and NCE, although the double
negative control will be sufficient for nonparametric identification of the ATE as detailed in
Section 3.2.
Figure 1 illustrates a directed acyclic graph (DAG) encoding the above assumptions.
Consider a study of the effectiveness of flu shot (A) on influenza-related hospitalization (Y ).
A major concern in such studies is potential hidden bias due to unmeasured health-seeking
behavior (U), a well-known common cause of flu shot status and influenza hospitalization.
In such a study, routinely captured information on a person’s annual wellness visit history
entails a good candidate NCE (Z) satisfying Assumption 4, as it reflects a person’s tendency
to engage in healthy behavior, and is unlikely to cause influenza hospitalization. Similarly,
recorded data on a person’s injury/trauma hospitalization provides compelling candidate
NCO(W ) satisfying Assumption 3, as it is likely associated with health-seeking behavior and
unaffected by flu shot. In addition, we can view an instrumental variable (IV) as an NCE
[12, 17]. An IV is a pre-treatment variable satisfying the following three core assumptions:
(IV relevance) the IV must be associated with the treatment; (Exclusion restriction) the
IV must not have a direct effect on the outcome that is not mediated by the treatment;
(IV independence) the IV must be independent of unmeasured confounders. For example,
physician’s prescribing preference is often taken as an IV in comparative effectiveness studies,
because it likely induces variation in the choice of treatment, and may not affect the outcome
other than through its influence on the treatment [18]. A valid IV satisfies Assumption 4 and
hence is a valid NCE, which is further explained in Section 3.1. Besides the above three IV
conditions, a forth condition is necessary to identify a causal effect, such as the monotonicity
assumption or the no current treatment interaction assumption [19–22]. Alternatively, causal
effect identification using IV is also made possible by further incorporating an NCO under
a double negative control framework introduced in Section 3.2.
It is important to note that Figure 1 is not the only DAG satisfying the negative control
assumptions. For example, a more general DAG would allow Z to affect A, corresponding
to the case where an annual wellness visit could result in flu vaccination during flu season.
Moreover, physician preferences are not randomized and may be associated with U via
physician-patient interactions, potentially violating the IV independence assumption. Such
an invalid IV violating the IV independence assumption is still a valid NCE as long as the
exclusion restriction holds, regardless of whether the IV relevance assumption holds. In this
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case, an NCO can be used to repair an invalid IV for causal effect identification under a
double negative control framework [12, 17]. Additional DAGs illustrating settings in which
Assumptions 2-3 hold are provided in Table A.1 of the Appendix. As demonstrated in
[12] and [17], an NCE can be either pre- or post-treatment variable. Unmeasured common
causes of the Z-A association and Y -W association can also be present without necessarily
invalidating Assumptions 3-4. A key insight is that a valid NCO does not necessarily need
to be an outcome variable and may in fact precede the treatment in view, while a valid NCE
need not necessarily be a treatment and may in fact be ascertained either together with
primary outcome of interest or subsequently.
1.2 Inconsistent terminology in literature
In prior literature, NCO has been referred to as falsification outcome/end point [23–26],
control outcome [14, 27, 28], secondary outcome [29, 30], supplementary response [6] and
unaffected outcome [31]. NCE has been referred to as control exposure [27] and residual-
confounding indicator [32, 33]. Both NCO and NCE have been referred to as proxies of
unmeasured confounder [34–36]. In addition, an exposure-outcome pair known a priori to
be unrelated has also been referred to as a negative control pair [37–41].
The literature reviewed in the current paper is largely limited to papers that use afore-
mentioned nomenclature. Although [3] and [27] review negative control literature, to the
best of our knowledge, this paper is the first to systematically summarize both formal causal
and statistical methodology together with applications of negative controls. The rest of the
paper is organized as follows. Design and validation of negative controls are discussed in Sec-
tion 2. We then review both assumptions and methods for using negative controls to detect,
reduce, and remove unmeasured confounding bias in Section 3. We use a simple example to
illustrate double negative control adjustment (i.e., leveraging NCE and NCO when both are
available) of confounding bias in Section 3.2. We close with a summary in Section 4.
2 Review of applications
Existing applications of negative controls mainly focus on detection of uncontrolled con-
founding bias. We list in Table 1 selected studies that employed negative controls to detect
residual confounding and to strengthen causal conclusions. Among these studies, eight used
NCEs and nine used NCOs. Table 1 is by no means comprehensive, as hundreds of stud-
ies have leveraged negative control variables as evidenced by the number of recent articles
that have cited [3] as the foundational paper on the use of negative control exposures and
outcomes in Epidemiology, but rather a representative set of examples that help illustrate
strategies for identifying compelling candidate negative controls.
2.1 Examples of negative control designs
Effect of influenza vaccination on influenza hospitalization: using injury/trauma
hospitalization as an NCO As detailed in Section 1.1, to study the effects of influenza
vaccination on influenza hospitalization in the elderly, injury/trauma hospitalization was
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taken as an NCO to detect confounding by unmeasured health-seeking behavior [14]. In-
fluenza hospitalization before the flu season was also used as an NCO, because flu vaccine
can not protect against influenza hospitalization when there is little flu virus circulation.
Effect of maternal exposure on offspring outcomes: using paternal exposure as
an NCE A number of publications have used paternal exposure as an NCE to study the
intrauterine effect of maternal exposure on offspring outcome. Specifically, [42–46] studied
the association between maternal smoking and offspring outcomes, and compared paternal
and maternal associations to detect potential bias due to unmeasured confounding by family-
level confounding factors or parental phenotypes. Similarly, [47] compared maternal and
paternal distress and their associations with offspring asthma. Evaluation of the validity of
paternal exposure as an NCE has also been considered in [48]. They found that cotinine level
from exposure to partner smoking were low in non-smoking pregnant women, which suggests
that using paternal smoking as an NCE for investigating intrauterine effects is valid.
Effect of air pollution on health outcomes: using future air pollution as an NCE
Besides use of paternal exposures, NCEs are also used in air pollution studies. For example,
[32, 33, 49, 50] studied statistical methods that utilize future air pollution as an NCE for bias
detection and bias reduction, because the future is not expected to causally affect the past.
In addition, [51] studied the effect of air pollutant on asthma, and leveraged two different
NCEs: air pollutant level in the future and air pollutant level in a distant city.
2.2 Summary of negative control designs
In addition to the above examples, various negative control designs are also summarized in
Table 1. Rather than detailing each study in Table 1, we summarize these studies in terms
of their respective strategy to identify negative control variables below. A commonly used
strategy to select negative controls leverages temporal and spacial constraints that essen-
tially guarantee the exclusion restrictions in Assumptions 3-4. Temporal ordering leverages
the universal truth that the future cannot causally affect the past. For example, as detailed
above, [32, 33, 49–51] specify future measurements of air pollution as an NCE to study the
effect of current air pollution on health outcomes. Similarly, [46] proposed to look at ma-
ternal exposure before and after pregnancy in studying the intrauterine effect of maternal
exposure on offspring outcome. An essential prerequisite for this design is that primary
outcome does not cause subsequent exposure (at least in the short term), certainly a reason-
able assumption in air pollution settings. Prior information about timing of exposure also
sometimes allows one to leave out an essential ingredient [3]. For instance, [14] defined as
NCO the number of hospitalizations prior to influenza season in order to estimate the effect
of influenza vaccination on influenza hospitalization, as little to no flu circulates prior to flu
season for influenza vaccination to be protective against. Spatial distancing has also been
considered as an effective means to enforce exclusion restrictions in Assumptions 3-4. For
instance, [51] took air pollutant level in a distant city as an NCE to study the effect of air
pollutant on asthma. [52, 53] studied screening sigmoidoscopy and mortality from colon tu-
mor, and selected tumor from proximal colon that is beyond the reach of the sigmoidoscopy
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Reference Exposure Outcome Negative Control Exposure Negative Control Outcome
[42] Maternal smoking Low birth weight Paternal smoking
[43] Maternal smoking Sudden infant death
syndrom
Paternal smoking
[44] Maternal smoking Offspring height, ponderal
index, body mass index
Paternal smoking
[45] Maternal smoking Offspring blood pressure Paternal smoking
[47] Maternal distress Offspring asthma Paternal distress
[46, 48]: Maternal smoking, alcohol
use or dietary patterns
Offspring development Paternal smoking, alcohol use or
dietary patterns
[51] Air pollutant Ashma Future air pollutant, air
pollutant elsewhere
[54] Mammography-screening
participation
Death from breast-cancer Dental-care participation Death from causes other than
breast cancer and from external
causes such as accidents,
intentional self-harm and assaults
[14] Influenza vaccination Mortality and
pneumonia/influenza
hospitalization
Outcome before and after influenza
season; injury/trauma
hospitalization
[55] Air pollutant Asthma hospitalization Appendicitis hospitalization
[56–59] Smoking Mortality from lung
cancer
Other causes of death
[60] Psychological stress post
earthquake
Deaths from cardiac
events
Other causes of death, e.g. cancer
[52, 53] Screening sigmoidoscopy Mortality from distal
colon tumor
Mortality from proximal colon
tumor (above the reach of the
sigmoidoscopy)
Table 1: Summary of selected applications using negative controls for detection of confounding bias.
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as an NCO.
Another strategy is to select as NCO an outcome analogous to the primary outcome how-
ever resulting from mechanism a priori known to be unrelated to the primary treatment. As
illustration of this approach, consider [14] which took hospitalization due to injury/trauma
as an NCO for the primary outcome, hospitalization due to influenza. Similarly, to evalu-
ate the effect of air pollution on hospitalization due to asthma, [55] defined hospitalization
due to appendicitis as an NCO. In addition, several studies routinely use death from other
causes as NCO: [56–59] studied the effect of smoking on lung cancer with mortality from
other causes as an NCO, [60] studied the effect of psychological stress on deaths from car-
diac events after an earthquake with death from other causes as an NCO, and [54] selected
death from causes other than breast cancer and from external causes such as accidents, in-
tentional self-harm and assaults as NCO to estimate the effect of mammography-screening
participation on breast cancer mortality.
2.3 Validation of negative controls by subject matter knowledge
Despite the various strategies in the literature to find candidate negative controls, researchers
should rigorously validate the choice of negative controls and be aware of possible violations
of negative control assumptions. Similar to the assumptions of no unmeasured confounding,
negative control assumptions (Assumptions 3 and 4) are causal assumptions that can only
be established by subject matter considerations and not by empirical test without additional
assumptions. In practice, we recommend checking the following criteria in finding a candidate
negative control.
• “Irrelevant to Y (or A)”: The NCE should not cause the outcome of interest, while the
NCO should not be caused by the treatment of interest nor the NCE. These conditions
are formally implied by Assumptions 3 and 4.
• “Comparable to A (or Y )”: In most cases it is important to have the source of bias in
mind before designing a negative control study although this is not always necessary
[12, 13]. Unmeasured confounding mechanism of negative controls should be com-
parable to that of A and Y in the following sense: the NCE must be associated with
unmeasured confounders conditional on measured confounders and primary treatment;
the NCO must be associated with unmeasured confounders conditional on measured
confounders. Hence the negative control variable is often viewed as a proxy of the
unmeasured confounders. A variable completely irrelevant to all mechanisms under
consideration would not provide any useful information. These conditions are for-
mally required by Assumptions 5 and 7 in Section 3;
• “Adequate Negative Control Power”: The NCE and NCO are not exceedingly rare
relative to primary treatment and outcome variables, respectively. For example, in the
event that the negative control variable is a rare binary variable, or if the association
between unmeasured confounder and negative control variable is weak, then large sam-
ple may be necessary to achieve sufficient power for detecting confounding bias [61,
62].
We list examples of possible violations of negative control assumptions in the Appendix.
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3 Review of methods
3.1 Bias detection
Key assumption and rationale for bias detection Assumptions 3 and 4 give rise to
formal statistical tests of the null hypothesis that adjustment for observed covariates suffices
to control for confounding bias, rejection of which indicates presence of an unmeasured
confounder U . A key assumption for this bias detection strategy is that the negative control
exposure or outcome is U -comparable to the primary exposure or outcome:
Assumption 5 (U -comparable). W 6⊥⊥ U | X and Z 6⊥⊥ U | A,X.
The U -comparability assumption requires that unmeasured confounders U of A-Y as-
sociation are identical to those of the A-W association and Z-Y association, such that a
non-null A-W or Z-Y association can be attributed to U . Therefore, presence of an associa-
tion between primary and negative control variables implies residual confounding bias, while
absence of such associations implies no empirical evidence of unmeasured confounding. It is
important to note that when evaluating Z-Y association one must also adjust for A to rule
out the potential association between Z and Y due to the pathway Z − A→ Y (the arrow
between Z and A could either be Z → A or Z ← A). Examples of such relationships are
listed in Table A.1 of the Appendix. Notably, conditional on X, a valid IV independent of
U and associated with A satisfies Assumption 5 because of conditioning on a collider A on
the IV→ A← U pathway [12, 17]; likewise an invalid IV that violates the IV independence
assumption defined in Section 1.1 would also satisfy Assumption 5 regardless of whether IV
and A are associated, as mentioned in Section 1.1.
Methods As detailed in Section 2, majority of existing applications used negative con-
trols for bias detection, by testing for an association between primary and negative control
variables. A review of bias detection methods is presented in Table 2. For example, [32]
formalized bias detection as a Wald test of the coefficient of NCE in a regression model
of the outcome on the primary and negative control exposures. Moreover, [63, 64] noted
that an invalid NCE that violates the exclusion restriction but satisfies the U -comparable
assumption can nevertheless validate a causal interpretation when it does not appear to be
associated with the outcome adjusting for the treatment of interest.
3.2 Bias reduction and bias correction
Summary of literature Beyond bias detection, recent developments have made it possible
to reduce and sometimes completely remove unmeasured confounding bias using negative
controls. In air pollution studies, current and future pollutant levels are often positively
correlated and are associated with unmeasured confounders in the same direction. In this
setting, [33] showed that incorporating future air pollution, an NCE, in the outcome model
can reduce confounding bias. Further bias attenuation was proposed in [49] by incorporating
both past and future exposures. Bias reduction using an NCO was considered by [65] in
estimation of standardized mortality ratio, where the standardized mortality ratio of the
NCO was used to reduce bias in that of the primary outcome. In addition, [38, 40] considered
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Reference and Setting Main Assumptions Besides Assumptions 2-5 Methods
D
[32]: Time-series study.
Z = future air pollution At+1.
(1) At+1 ⊥ Yt | At, Ut, Xt.
(2) log[E(Yt)] = α+ βAt + γXt + βfAt+1.
Bias detection by Wald-test on βf .
[63, 64]: invalid NCE Z. (1) Violation of exclusion restriction Y (a, z) 6= Y (a).
(2) Z is U -comparable with A: Z 6⊥⊥ U | A,X.
No evidence of Z-Y association adjusting for A
implies no residual confounding of A-Y association.
R
[33, 49]: Time-series study.
Z = future air pollution At+1.
(1) At+1 ⊥ Yt | At, Ut, Xt; At+1 6⊥⊥ (At, Ut) | Xt.
(2) Yt(at, xt, ut) = β0 + β1αt + β2xt + β3ut + t;
E[t | At = at, Ut = ut, Xt = xt] = 0.
(3) E[Ut | At = at, At+1 = at+1, Xt=xt ] =
α0 + α1at + α2xt + α3at+1; sign(α1) = sign(α3).
(4) E[At+1 | At=at, Xt=xt]=γ0+γ1at+γ2xt; γ1 > 0.
Bias reduction by fitting E[Yt | At, Xt, At+1] instead
of fitting E[Yt | At, Xt]. Further bias reduction
considered in [49] by incorporating Xt+1 or At−1.
Identification of β1 is possible with multiple future
exposures under autoregressive model for exposure
time series.
[65]: Standardized mortality
ratio in occupational cohort
study.
(1) E[Y (1) | X = k]/E[Yref | X = k] = exp(αk − δk)
E[W | X = k]/E[Wref | X = k] = exp(−k).
(2) sign(k) = sign(δk) and 0 < |k| < 2|δk|.
Adjust for bias δk via E[Y (1) | X = k]E[Wref | X =
k]/E[Yref | X = k]E[W | X = k].
[38, 40]: Define negative
controls as drug–outcome
pairs where one believes no
causal effect exists.
(1) For a negative control drug-outcome pair, the effect
estimate βi ∼ N(θi, τ2i ), i = 1, . . . , n, where θi ∼ N(µ, σ2)
is the true bias.
(2) Under the null of no treatment effect, the effect
estimate βn+1
H0∼ N(µ, σ2 + τ2n+1).
Estimate µ, σ by MLE with
L(µ, σ | θ, τ) = Πni=1
´
p(βi | θi, τi)p(θi | µ, σ)dθi.
Calibrated p-value computed via Wald-test of βn+1.
Confidence interval calibrated similarly using
distribution generated by positive controls.
C
[66, 67]: W,Y=
Time-to-event outcome.
(1) There exist monotonic functions that describe U -Y
and U -W associations: Y (0) = hy(U,X),W = hw(U,X).
(2) Cox models for Y and W w/ hazard ratio eβy and eβw .
The hazard ratio measuring the causal effect of
treatment is eβy−βw .
[13, 68]: Generalized
difference-in-differences using
NCO.
(1) There exist monotonic functions that describe U -Y
and U -W associations: Y (0) = hy(U,X),W = hw(U,X).
(2) Positivity: if 0 < fW |A=1,X(W ∗) then
0<fW |A=0,X(W ∗)<1, where W ∗ = (W | A = 1, X) is
distributed as W in the exposed group.
The average treatment effect on the treated is
E[Y (1)− Y (0) | A = 1] = E[Y | A =
1]−E[F−1Y |A=0,X) · FW |A=0,X(W ∗)]. Generalized the
difference-in-differences approach to the broader
context of NCO.
[69]: Calibration using NCO. (1) W ⊥ A | X,Y (1), Y (0). (2) Rank preservation:
Y = Y (0) + ΨA, and hence W ⊥ A | X,Y (0) by (1).
(3) E[W |A, Y (0)=Y −ΨA,X]=β1+β2X+β3Y (Ψ)+β4A,
where β4 = 0 by (1).
The 95% CI for any Ψ0 consists of all Ψ for which
βˆ4(Ψ)± 1.96s.e.[βˆ4(Ψ)] contains 0; Under (1)-(3), fit
E[W | A, Y,X] = β1 + β2X + β3Y + βΨA, then the
causal effect Ψ = −βΨ/β3.
[70–72]: Removing unwanted
variation in gene-expression
analysis.
(1) Y1×p = X1×qβq×p + U1×rΓr×p + 1×p, p ≥ r + 1.
(2) W1×s = U1×rΓWr×s + W1×s, s ≥ r,Rank(ΓWr×s) = r.
(3) (, W ) ∼ N(0, diag(σ21, . . . , σ2p+s)), (, W ) ⊥⊥ (X,U).
(4) U1×r = Xqαq×r + U1×r, U ∼ N(0, Ir), U ⊥⊥ X.
[70, 71]: Estimate U by factor analysis of (2), then
estimate β from (1). [72]: Estimate ΓW and Γ by
factor analysis of Y = X(β + αΓ) + (UΓ + ) (5) and
W = XαΓW + (UΓW + W ) (6). Then estimate α
from (6), and estimate β from (5).
[12, 17, 36]: Nonparametric
identification.
Assumption 7 Identify h in E[Y |A,Z,X] =E[h(W,A,X) |A,Z,X],
then ATE = E[h(W,A = 1, X)]− E[h(W,A = 0, X)].
Table 2: Summary of published methodologies using negative controls for detection (D), reduction (R), and correction (C) of confounding bias.
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calibrating p-value and confidence intervals by deriving an empirical null distribution from
the association between primary and negative control variables.
Several methods were developed to achieve full bias removal, under certain assumptions
such as monotonicity [13, 66–68], rank preservation [69], and linear model for unmeasured
confounding. Specifically, [66, 67] considered bias correction by using a negative control
time-to-event outcome under a monotonicity assumption that describes the U -Y and U -
W association. Under a similar monotonicity assumption, [13] generalized difference-in-
difference method to NCO method, which is further extended by [68]. In addition, [69]
developed an outcome calibration approach with a rank preservation assumption under which
the counterfactual primary outcome can account for the unmeasured confounding between
the A-W association. Lastly, [70–72] assumed a linear model for the unmeasured confounder
and proposed to estimate U by factor analysis.
Nonparametric identification in a double negative control design The above meth-
ods remove unmeasured confounding bias under relatively stringent assumptions. [36] es-
tablished sufficient conditions under which the ATE can be nonparametrically identified
leveraging an NCE and an NCO, i.e., via a double negative control design [17]. That is, the
ATE can be uniquely expressed as a function of the observed data distribution without im-
posing any restriction on the observed data distribution, such that distinct data generating
mechanisms are guaranteed to lead to distinct ATE values. Further method developments
include semiparametric estimation under categorical negative controls and unmeasured con-
founding [17] and alternative strategies to identify the ATE via a so-called confounding
bridge function [12].
Double negative controls are widely available in health sciences. For example, in air pollu-
tion studies, [12] used future air pollution level and past health outcome as negative control
exposure and outcome, respectively. [17] took two routinely monitored control outcomes
from administrative healthcare data in vaccine safety studies as double negative control, in
the setting where both control outcomes are independent of the primary outcome and satisfy
both Assumption 3 and Assumption 4. In influenza vaccine effectiveness research presented
in Figure 1, annual wellness visit and injury/trauma hospitalization can serve as double
negative control. In addition, when IV is available, identification is made possible by further
incorporating an NCO such as a pretreatment measurement of the outcome.
Below we will first detail the identification conditions established in [36] and then intro-
duce identification methods proposed in [36] and [12].
Assumption 6 (Positivity). 0 < P (A = a, Z = z | X) < 1 for all a, z.
Assumption 7 (Completeness). (a) For all a, W 6⊥⊥ Z | A = a,X. (b) For any square
integrable function g, if E[g(W )|Z = z, A = a,X] = 0 for almost all z, a, then g(W ) = 0.
Assumption 6 is a regular positivity assumption ensuring that in all strata of X, there
are always some individuals with A = a, Z = z for all a, z. Assumption 7 is a commonly
used completeness condition for identification [73]. Specifically, Assumption 7(a) essentially
requires U -comparability. That is, both Z and W should be associated with U such that
variation in U can be recovered from variation in Z and W . Assumption 7(b) aims to ensure
that the underlying unmeasured confounding mechanism in E[Y | A,U ] can be identified
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using Z and W . For example, suppose U is a binary variable. Then Assumption 7 further
requires that Z and W have at least two categories, and E[W | A = a, Z = 1, X = x]−E[W |
A = a, Z = 0, X = x] is not equal to zero for all a, x.
Rationale In the presence of unmeasured confounding by a latent variable U , an observed
difference in the outcome between the treatment and control groups is a combination of
the underlying causal effect and confounding bias. One cannot directly disentangle the
variation in the outcome due to the treatment from the unwanted variation due to U , as U
is not measured. We seek to indirectly remove such unwanted variation, i.e., unmeasured
confounding bias, by leveraging available proxies of U . An important example of such proxy is
an NCO chosen to be associated with U but not causally affected by the treatment (Figure 1).
Therefore, any difference in the NCO, W , between the treatment and control groups can only
be attributed to U . Such a difference can uncover the unwanted variation due to U assuming
that U -Y and U -W associations are the same, and there is no U -A additive interaction on
Y . An example of such W is the pre-exposure baseline measure of the outcome, in which
case bias adjustment reduces to the well-known difference-in-differences approach [13].
The above describes identification of the ATE under assumptions that are generally
untenable, because the U -Y and U -W associations will often be on different scales, and
there may be U -A interactions in the model for Y . In order to nonparametrically identify
unmeasured confounding bias, we make use of the NCE Z. Because Z is associated with Y
or W only through U , the ratio of Z-Y and Z-W associations captures the ratio of U -Y and
U -W associations, allowing for U -A interactions. In summary, leveraging a double negative
control design one can nonparametrically identify the magnitude of unmeasured confounding
bias via the following mechanism: The NCO uncovers the confounding bias up to a scale
that reflects the difference between U -Y and U -W associations, while the NCE recovers the
scale leveraging Z-Y and Z-W associations. This mechanism is further illustrated in an
example below.
Example To further illustrate the idea of identification using double negative control,
consider a simple example where we assume the following linear structural equation models
involving unmeasured confounding U , although the nonparametric identification proposed
in [36] does not rely on any restriction about the data generating models. We suppress
measured confounders X to ease notation – all arguments are made implicitly conditional
on X.
Had U been measured, we could fit (1) and obtain the true causal effect which is βYA.
When in fact U is not measured, to leverage double negative control, we additionally assume
the U -W relationship in (2) and U -Z relationship in (3).
E[Y | A,U ] = βY0 + βYAA+ βYUU (1)
E[W | U ] = βW0 + βWUU (2)
E[U | A,Z] = βU0 + βUAA+ βUZZ. (3)
Models (1)–(3) indicate the following models that one could actually fit using the observed
data (Y,A,W,Z). These models are obtained by replacing U with E[U | A,Z] in the primary
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and negative control outcome models (1) and (2).
E[Y | A,Z] (1)= βY0 + βYAA+βYUE[U | A,Z] (4)
(3)
= βY0 + βYAA+βYU(βU0 + βUAA+ βUZZ) (5)
E[W | A,Z] (2)= βW0+ βWUE[U | A,Z] (6)
(3)
= βW0+ βWU(βU0 + βUAA+ βUZZ). (7)
From (1) we know that the true causal effect is βYA. However, if one were to regress Y
on A and Z without accounting for U such as in [33], then the coefficient of A would be
equal to βYA + βYUβUA. Here βYUβUA is confounding bias, which arises when there exists a U
that is associated with both Y and A. One cannot directly separate the confounding bias
from the true causal effect because U is not observed. Nevertheless, the coefficients in the
observed models (5) and (7) allows us to infer βYUβUA. To facilitate discussion, we introduce
notation for the coefficients in models (5) and (7). Let δYA = βYA + βYUβUA and δ
Y
Z = βYUβUZ
denote the coefficients of A and Z in the primary outcome model (5), respectively, and let
δWA = βWUβUA and δ
W
Z = βWUβUZ denote the coefficients of A and Z in the negative control
outcome model (7), respectively.
We detail three strategies to identify the unmeasured confounding bias βYUβUA leveraging
a single NCO, a single NCE, or the double negative control. First, we note that coefficient
of A in the primary outcome model, δYA , is a combination of both true causal effect and
confounding bias, whereas coefficient of A in the negative control outcome model, δWA , reflects
pure confounding bias because A does not causally affect W . In fact, if U -Y and U -W
associations are equal on the additive scale, i.e., βWU = βYU, then δ
W
A matches the confounding
bias βYUβUA. That is, under the assumption of equal U -Y and U -W additive association, a
form of “additive outcome equi-confounding” [13], the treatment effect on NCO is equal to
the unmeasured confounding bias. Hence the causal effect can be recovered by backing out
the association of the treatment with the NCO from the association of the treatment with
the primary outcome. Note that in this scenario it is not necessary to have an NCE: one can
fit the primary and negative control outcome on treatment without adjusting for the NCE,
and then take the difference in treatment effects. When NCO is the baseline outcome, the
above reduces to the difference-in-difference method [13].
Second, the coefficient of Z in the primary outcome model, δYZ , would be zero if there was
no unmeasured confounding because Z does not causally affect Y . Therefore, coefficient of
Z in the outcome model reflects pure confounding bias. In fact, if U -A and U -Z associations
are the equal on the additive scale, i.e., βUA = βUZ, then δ
Y
Z captures the bias βYUβUA due
to unmeasured confounding. That is, under the assumption of equal U -A and U -Z additive
association, a form of “additive treatment equi-confounding”, the NCE effect on the primary
outcome is equal to the unmeasured confounding bias. Hence the causal effect is given by
the difference in coefficients of treatment and NCE in the primary outcome model. Note
that in this scenario it is not necessary to have an NCO: one can fit the primary outcome
on treatment and NCE, and then take the difference in effects of treatment and NCE on Y .
In both scenarios described above, the “additive outcome equi-confounding” or “additive
treatment equi-confounding” is a rather strong assumption, as it requires Y and W , or Z
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and A, to operate on the same scale. To relax these assumptions, we can leverage the
double negative control. Specifically, if U -Y and U -W associations are unequal, then δWA
reflects pure confounding bias up to a scale which is equal to βYU/βWU. Because Z-Y (Z-W )
association is a product of U -Z and U -Y (U -W ) associations, the ratio of Z-Y and Z-W
associations is equal to the ratio of U -Y and U -W associations. That is, βYU/βWU = δ
Y
Z /δ
W
Z .
The confounding bias is thus equal to δWA scaled by δ
Y
Z /δ
W
Z , and the true causal effect is give
by δYA − δWA × δYZ /δWZ . It is important to note that the first two adjustment methods are a
special case of the general adjustment method, in that the confounding bias is always equal
to δWA δ
Y
Z /δ
W
Z across all three scenarios.
To summarize, the confounding bias
βYUβUA = δ
W
A δ
Y
Z /δ
W
Z =

δWA if βWU = βYU
δYZ if βUA = βUZ
δWA δ
Y
Z /δ
W
Z if βWU 6= βYU and βUA 6= βUZ.
(8a)
(8b)
(8c)
Hence the true causal effect is identified as
βYA = δ
Y
A − δWA δYZ /δWZ . (9)
It is important to note that equation (9) is only meaningful when δWZ is not equal to zero.
If δWZ = 0 then either there is no evidence of the presence of U and βYUβUA = 0, or a se-
lected negative control variable is not sufficiently associated with U , violating Assumption 7.
Similar arguments apply to δWA and δ
Y
Z . In fact, as summarized in Table 2, many negative
control methods detect, reduce, and remove unmeasured confounding bias using analogies of
scenario (8a) [13, 65–67] and scenario (8b) [32, 33, 49].
In practice, identification via (9) relies on fitting the primary and negative control out-
come models E[Y | A,Z] and E[W | A,Z]. Alternatively, one could directly make as-
sumption about the underlying unmeasured confounding mechanism E[Y | A,U ] which is
proposed in [12]. To illustrate, consider again the example above. Let U˜W =
W−β0
βWU
, then
by (2) U˜W is a good proxy of U in the sense that E[U˜W | U ] = U . In particular, let
h(W,A) = βY0 + βYAA+ βYUU˜W , then by (1) we have
E[Y | A,U ] = E[h(W,A) | A,U ], (10)
E[Y | A,Z] = E[h(W,A) | A,Z], (11)
where (11) is obtained by taking expectation on both sides of (10). The above equations
indicate that h captures the relationship between U -Y and U -W associations via (10), which
can be identified by the relationship between Z-Y and Z-W associations via (11). Because
of this key observation, h is referred to as the confounding bridge function in [12]. The
functional form of h is implied by (1) and (2). Once h is identified, we have that E[Y (a)]
(10)
=
EU{E[Y | A = a, U ]} = E[h(W,A = a)]. In practice, one may assume a familiar linear
model about the functional form of h that satisfies (10), such as
h(W,A; θ) = θ0 + θAA+ θWW. (12)
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Then under Assumption 7, θ can be identified by the population moment equation E[g(A,Z){Y−
h(W,A; θ)}] = 0 using the generalized method of moments (GMM) method [74]. With θ
identified, the ATE is given by
ATE = E[h(W,A = 1; θ)]− E[h(W,A = 0; θ)]. (13)
A simple version of the above GMM procedure can be realized via a simple two stage least
squares procedure as followed [12]:
Stage I: regress W on A and Z (with intercept), and obtain the fitted value Ŵ as a proxy of U ;
Stage II: regress Y on and A (with intercept), adjusting for Ŵ ,
then the coefficient of A is the true causal effect βYA assuming (1) and (2). The two stage
least squares approach given above provides a simple implementation of the NC method
using existing and widely disseminated IV software packages such as the ivregress, ivreg,
or ivreg2 command in Stata, the gmm, sem, ivpack, or AER package in R, and the SYSLIN
procedure in SAS.
4 Conclusions
Negative controls are innovative and important tools in observational studies. Develop-
ment of negative control methods will encourage researchers to routinely check for evidence
of confounding bias and rigorously adjust for residual confounding bias. Negative control
variables are widely available in routinely collected healthcare data such as administrative
claims and electronic health records data, because information on secondary treatments and
outcomes beyond the primary treatment and outcome of interest are often recorded, and
such secondary treatments and outcomes can potentially serve as negative controls. There-
fore development of negative controls methods is critical to unlocking the full potential of
contemporary healthcare data and ultimately improve the validity of research findings. It
is important to note that other sources of bias, such as selection bias and misclassification
bias, are typical in routinely collected healthcare data. Developing negative control methods
accounting for bias beyond residual confounding is thus an important area of future research.
We have specified statistical assumptions, practical strategies, and validation criteria
that can be combined with subject matter knowledge to design negative control studies in
Section 2. We also illustrated identification of the ATE by either fitting the observed primary
and negative control outcome models or through assumption on the unmeasured confounding
mechanism followed by a simple two stage least squares procedure in Section 3. We believe
that these examples can provide practical guidance on use of negative control methods to a
broader audience.
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Appendix
A.1 Examples of invalid negative controls that violates some as-
sumption
Violation 1: no arrow between U and W There must be an arrow between U and W ,
because an NCO is a proxy of unmeasured confounder. It recovers the confounding bias by
reflecting variation due to U .
Violation 2: no arrow between U and Z, and Z6→A The only scenario that Z does
not need to be associated with U is when Z is an instrumental variable (see first cell of
Table A.1). In this case, A is a collider between Z and U , such that Z and U are marginally
independent. Conditioning on a collider will create collider bias such that Z and U become
conditionally dependent. The requirements about Z in Assumptions 5 and 7 are all made
conditioning on A. Therefore an instrumental variable is a valid NCE.
Violation 3: Y→W If the outcome causes the NCO, then the treatment directly causes
the NCO via the path A→ Y → W , which violates Assumption 3.
Violation 4: Z→U←W The direction of the arrow between U and the negative control
doesn’t always matter. For example, we can have Z → U , U → Z, W → U , or U → W .
However, if both Z and W cause U , then U is a collider in the path Z → U ← W . In this
case, conditional on U , Z and W will become associated. This violates Assumption 2.
A.2 Example of causal graphs encoding the negative control as-
sumptions
Below we enumerate the possible relationships among Z,A, U and among Y,W,U in Ta-
ble A.1. These partial graphs can be combined into a directed acyclic graph that encodes
the negative control assumptions. Grey colored graphs are invalid because of violation of
key assumptions.
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Table A.1: Examples of graphs for Z,A, U relationships and for W,Y, U relationships. The two pieces of graphs can be combined in to a directed
acyclic graph that encodes the negative control assumptions. Grey colored graphs are invalid because of violation of key assumptions.
Examples of graphs for Z,A,U relationships
Z → A (pre-treatment) A→ Z (post-treatment) Z ⊥⊥ A
No arrow between Instrumental variable (IV) Violate Assumption 5 and 7 Violate Assumption 5 and 7
U and Z (may violate
A
U,X
YZ A
U,X
YZ A
U,X
YZAssumption 5 and 7)
Invalid IV Post-treatment proxy of U Surrogate of U
U → Z
A
U,X
YZ A
U,X
YZ A
U,X
YZ
May violate Assumption 2 if there is W → U
Z → U
A
U,X
YZ A
U,X
YZ A
U,X
YZ
Examples of graphs for W,Y,U relationships
W → Y (a) Y (a)→W Y (a) ⊥⊥W | (U,X)
(violate Assumptions 3 and 4)
No arrow between Violate Assumption 5 and 7 Violate Assumptions 3, 5, and 7 Violate Assumption 5 and 7
U and W (violate
A
U,X
Y W A
U,X
Y W A
U,X
Y WAssumption 5 and 7)
Violate Assumption 3
U →W
A
U,X
Y W A
U,X
Y W A
U,X
Y W
May violate Assumption 2 if there is Z → U
Violate Assumption 3
W → U
A
U,X
Y W A
U,X
Y W A
U,X
Y W
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